Tumor-suppressive effects of psoriasin (S100A7) are mediated through the β-catenin/T cell factor 4 protein pathway in estrogen receptor-positive breast cancer cells.

Tumor-suppressive effects of psoriasin (S100A7) are mediated through the β-catenin/T cell factor 4 protein pathway in estrogen receptor-positive breast cancer cells.

Item
http://www.wikidata.org/entity/Q35639956
The secreted protein S100A7 (psoriasin) is induced by telomere dysfunction in human keratinocytes independently of a DNA damage response and cell cycle regulatorsS100A7 promotes the migration, invasion and metastasis of human cervical cancer cells through epithelial-mesenchymal transitionDifferential role of psoriasin (S100A7) in estrogen receptor α positive and negative breast cancer cells occur through actin remodelingFAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway.S100A8 and S100A9 are associated with colorectal carcinoma progression and contribute to colorectal carcinoma cell survival and migration via Wnt/β-catenin pathway.miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.S100 proteins in cancer.Functions of S100 proteins.Distinct prognostic values of S100 mRNA expression in breast cancer.S100 protein family in human cancer.Joining S100 proteins and migration: for better or for worse, in sickness and in health.Increased S100A15 expression and decreased DNA methylation of its gene promoter are involved in high metastasis potential and poor outcome of lung adenocarcinoma.S100A7 acts as a dual regulator in promoting proliferation and suppressing squamous differentiation through GATA-3/caspase-14 pathway in A431 cells.Cannabinoid receptor-2 agonist inhibits macrophage induced EMT in non-small cell lung cancer by downregulation of EGFR pathway.S100A7 has an oncogenic role in oral squamous cell carcinoma by activating p38/MAPK and RAB2A signaling pathway.
P2860

Tumor-suppressive effects of psoriasin (S100A7) are mediated through the β-catenin/T cell factor 4 protein pathway in estrogen receptor-positive breast cancer cells.

Item
http://www.wikidata.org/entity/Q35639956
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Tumor-suppressive effects of p ...... -positive breast cancer cells.
@ast
Tumor-suppressive effects of p ...... -positive breast cancer cells.
@en
type
label
Tumor-suppressive effects of p ...... -positive breast cancer cells.
@ast
Tumor-suppressive effects of p ...... -positive breast cancer cells.
@en
prefLabel
Tumor-suppressive effects of p ...... -positive breast cancer cells.
@ast
Tumor-suppressive effects of p ...... -positive breast cancer cells.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Tumor-suppressive effects of p ...... -positive breast cancer cells.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932